These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1234 related items for PubMed ID: 28606154

  • 1. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K.
    Mol Cancer; 2017 Jun 12; 16(1):103. PubMed ID: 28606154
    [Abstract] [Full Text] [Related]

  • 2. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R, Yu Z, Chen F, Xu H, Shen S, Chen W, Chen L, Su Q, Zhang L, Bi J, Zeng W, Li W, Huang X, Wang Q.
    Biomed Pharmacother; 2018 Jul 12; 103():1632-1642. PubMed ID: 29864952
    [Abstract] [Full Text] [Related]

  • 3. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M, Xue H, Wang Y, Shen Q, Jiang Q, Zhang X, Li K, Jia M, Jia J, Xu J, Tian Y.
    Int J Oncol; 2017 Mar 12; 50(3):975-983. PubMed ID: 28098858
    [Abstract] [Full Text] [Related]

  • 4. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis.
    Wang Y, Liu Z, Yao B, Li Q, Wang L, Wang C, Dou C, Xu M, Liu Q, Tu K.
    Mol Cancer; 2017 Jul 17; 16(1):123. PubMed ID: 28716020
    [Abstract] [Full Text] [Related]

  • 5. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 17; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 6. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma.
    Li D, Zhang Y, Zhang H, Zhan C, Li X, Ba T, Qiu Z, E F, Lv G, Zou C, Wang C, Si L, Zou C, Li Q, Gao X.
    J Exp Clin Cancer Res; 2018 Mar 05; 37(1):46. PubMed ID: 29506532
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-130b promotes proliferation and EMT-induced metastasis via PTEN/p-AKT/HIF-1α signaling.
    Chang RM, Xu JF, Fang F, Yang H, Yang LY.
    Tumour Biol; 2016 Aug 05; 37(8):10609-19. PubMed ID: 26861561
    [Abstract] [Full Text] [Related]

  • 8. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y, He X.
    Yonsei Med J; 2019 Mar 05; 60(3):267-276. PubMed ID: 30799589
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long non-coding RNA AGAP2-AS1, functioning as a competitive endogenous RNA, upregulates ANXA11 expression by sponging miR-16-5p and promotes proliferation and metastasis in hepatocellular carcinoma.
    Liu Z, Wang Y, Wang L, Yao B, Sun L, Liu R, Chen T, Niu Y, Tu K, Liu Q.
    J Exp Clin Cancer Res; 2019 May 14; 38(1):194. PubMed ID: 31088485
    [Abstract] [Full Text] [Related]

  • 11. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB.
    Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082
    [Abstract] [Full Text] [Related]

  • 12. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q, Wang C, Tu K, Liu Q.
    Biomed Pharmacother; 2017 Sep 30; 93():420-428. PubMed ID: 28666208
    [Abstract] [Full Text] [Related]

  • 13. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X, Wen H, Jing L, Yang Y, Wang W, Liang X, Nan K, Yao Y, Tian T.
    Cancer Sci; 2017 Apr 30; 108(4):620-631. PubMed ID: 28132399
    [Abstract] [Full Text] [Related]

  • 14. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
    Ma DN, Chai ZT, Zhu XD, Zhang N, Zhan DH, Ye BG, Wang CH, Qin CD, Zhao YM, Zhu WP, Cao MQ, Gao DM, Sun HC, Tang ZY.
    J Hematol Oncol; 2016 Jan 06; 9():1. PubMed ID: 26733151
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma.
    Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, Zhan GF, Feng JT, Sun JC, Huang XH.
    Cancer Lett; 2016 May 28; 375(1):73-83. PubMed ID: 26944318
    [Abstract] [Full Text] [Related]

  • 16. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL, Yin XR, Zhang SQ.
    Cell Physiol Biochem; 2018 May 28; 51(3):1179-1192. PubMed ID: 30481780
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA-148a Inhibits Hepatocellular Carcinoma Cell Growth via Epithelial-to-Mesenchymal Transition and PI3K/AKT Signaling Pathways by Targeting Death Receptor-5.
    Zhang N, Zhou J, Zhou Y, Guan F.
    Appl Biochem Biotechnol; 2022 Jun 28; 194(6):2731-2746. PubMed ID: 35267120
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.
    Xia H, Ooi LL, Hui KM.
    Hepatology; 2013 Aug 28; 58(2):629-41. PubMed ID: 23471579
    [Abstract] [Full Text] [Related]

  • 19. HSCs-derived COMP drives hepatocellular carcinoma progression by activating MEK/ERK and PI3K/AKT signaling pathways.
    Li Q, Wang C, Wang Y, Sun L, Liu Z, Wang L, Song T, Yao Y, Liu Q, Tu K.
    J Exp Clin Cancer Res; 2018 Sep 19; 37(1):231. PubMed ID: 30231922
    [Abstract] [Full Text] [Related]

  • 20. STYK1 promotes epithelial-mesenchymal transition and tumor metastasis in human hepatocellular carcinoma through MEK/ERK and PI3K/AKT signaling.
    Wang Z, Qu L, Deng B, Sun X, Wu S, Liao J, Fan J, Peng Z.
    Sci Rep; 2016 Sep 15; 6():33205. PubMed ID: 27628214
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 62.